Uremia; Chronic
8
4
4
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms
Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal
Prevention and Management of Cardiovascular and Cerebrovascular Complications in Maintenance Hemodialysis (MHD) Patients
Studies on Adsorption International Learning Initiative Global
Dynamic Breath VOC Profiling as a Non-invasive Tool to Assess Hemodialysis Adequacy
Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension
The Effect of LIPUS on the Maturation of Newly Constructed Autogenous AVF